DR. BLAKE PATERSON, MD
Osteopathic Medicine in Baltimore, MD

License number
Maryland 52491
Category
Osteopathic Medicine
Type
Critical Care Medicine
License number
Maryland 52838
Category
Osteopathic Medicine
Type
Critical Care Medicine
License number
Maryland G57717
Category
Osteopathic Medicine
Type
Critical Care Medicine
License number
Maryland 01054941A
Category
Osteopathic Medicine
Type
Critical Care Medicine
Address
Address
600 N. Wolfe St, Baltimore, MD 21287
Phone
(410) 502-0444
National Provider ID: 1730484999
LicenseFiles verified this license of Nov 7, 2017 at the National Plan and Provider Enumeration System.

Personal information

See more information about BLAKE PATERSON at radaris.com
Name
Address
Phone
Blake M Paterson
1000 Fell St, Baltimore, MD 21231

Professional information

Blake Paterson Photo 1

Ceo, Cerecor Inc
Position:
Co-founder and CEO at Cerecor, Inc, Assistant Professor at Johns Hopkins School of Medicine, Director at Kennedy Krieger Institute
Location:
Baltimore, Maryland Area
Industry:
Biotechnology
Work:
Cerecor, Inc since May 2011 - Co-founder and CEO Johns Hopkins School of Medicine - Baltimore, MD since Mar 2011 - Assistant Professor Kennedy Krieger Institute since 2009 - Director Greater Baltimore Committee 2007 - 2012 - Chair, Bioscience Cmtee Fells Laboratories LLC Jan 2011 - May 2011 - Co-founder NRZ Consulting LLC Apr 2008 - 2011 - Owner Johns Hopkins School of Medicine Oct 2008 - Apr 2009 - Visiting Consultant, Dept of Bioengineering Alba Therapeutics 2004 - 2008 - Founder, President, CEO Eli Lilly 2000 - 2003 - Executive Director Parke Davis / Warner Lambert (now Pfizer Global RD) 1998 - 2000 - Senior Director Arbor Research Corporation 1991 - 1998 - Founder, Chair and CEO Anesthesia Associates of Ann Arbor, PC 1988 - 1994 - Partner Massachusetts General Hospital 1984 - 1988 - Resident
Education:
Harvard Medical School 1983 - 1988
Anesthesiology & Critical Care, Internship, Residency & Fellowships University of Vermont College of Medicine 1979 - 1983
MD Tufts University 1974 - 1978
BS, Engineering
Skills:
Translational Medicine, Product Development, Strategic Planning, Marketing, Registration, Portfolio Management, Clinical Research, Medicine, Commercialization, Marketing Strategy, Therapists, Biotechnology, Lifesciences, Oncology, Drug Discovery, Pharmaceutical Industry, Technology Transfer, Clinical Trials, Cell Biology, Clinical Development, Vaccines, Business Strategy, Immunology
Honor & Awards:
• Leadership in Bioscience Award 2008 Greater Baltimore Committee • Leadership in Bioscience Award 2007 Greater Baltimore Committee • ACG Maryland Deal Of The Year 2006 • Maryland Incubator Company of the Year 2006 • Best Industry Academia Biotech Collaboration, 2006 Greater Baltimore Committee (“GBC”) • President's Global Achievement Award 2000 - Warner Lambert Company, for Brasil Neuropathic Pain Marketing Plan; President's Global Achievement Award 2000, for Gabapentin Pediatric Exclusivity Study

Blake Paterson Photo 2

Dr. Blake Paterson, Baltimore MD - MD (Doctor of Medicine)
Specialties:
Anesthesiology
Address:
600 N Wolfe St, Baltimore 21287
(410) 502-0444 (Phone)
1030 Fairmount Dr, Ann Arbor 48105
JOHNS HOPKINS HOSPITAL
600 N Wolfe St, Baltimore 21287
(410) 955-5080 (Phone), (410) 955-1464 (Fax)
Certifications:
Anesthesiology, 1988
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
600 N Wolfe St, Baltimore 21287
1030 Fairmount Dr, Ann Arbor 48105
JOHNS HOPKINS HOSPITAL
600 N Wolfe St, Baltimore 21287
The Johns Hopkins Hospital
1800 Orleans St, Baltimore 21287
Education:
Medical School
University of Vermont / College of Medicine
Graduated: 1983

Blake Paterson Photo 3

Use Of Tight Junction Antagonists In The Treatment Of Acute Lung Injury And Acute Respiratory Distress

US Patent:
2013028, Oct 31, 2013
Filed:
Mar 28, 2013
Appl. No.:
13/852569
Inventors:
Blake Paterson - Baltimore MD, US
Peter Ward - Baltimore MD, US
Alessio Fasano - Baltimore MD, US
Assignee:
ALBA THERAPEUTICS CORPORATION - Baltimore MD
UNIVERSITY OF MARYLAND, BALTIMORE - Baltimore MD
International Classification:
A61K 38/08, A61K 45/06
US Classification:
514 15, 514 217
Abstract:
The present application provides compositions and methods for treating acute lung injury and acute respiratory distress syndrome. The methods include administering one or more tight junction antagonists to the lung of a subject in need thereof.

Blake Paterson Photo 4

Use Of Tight Junction Agonists To Facilitate Pulmonary Delivery Of Therapeutic Agents

US Patent:
2009029, Dec 3, 2009
Filed:
Jul 6, 2009
Appl. No.:
12/498057
Inventors:
Alessio FASANO - West Friendship MD, US
Blake Paterson - Baltimore MD, US
International Classification:
A61K 39/00, A61K 39/145, A61K 39/165, A61K 39/20, A61K 39/275, A61K 39/05, A61K 39/07, A61K 39/08, A61K 39/10, A61K 39/102, A61K 38/28, A61K 38/08, A61P 37/00
US Classification:
4242091, 4241841, 4242121, 4242191, 4242321, 4242451, 4242461, 4242471, 4242531, 4242541, 4242561, 514 4, 514 15, 514 16, 514 17
Abstract:
The present invention provides materials and methods to facilitate the pulmonary delivery of therapeutic agents. In some embodiments, agonists of tight junctions (e.g., zonulin agonists) are used in compositions to facilitate the uptake of therapeutic agents from the pulmonary mucosa.

Blake Paterson Photo 5

Methods And Compositions For The Diagnosis Of Crohn's Disease

US Patent:
2009017, Jul 9, 2009
Filed:
Nov 7, 2008
Appl. No.:
12/266985
Inventors:
Julio BAI - Buenos Aires, AR
Alessio Fasano - West Friendship MD, US
Blake Paterson - Baltimore MD, US
Alicia Sambueli - Buenos Aires, AR
International Classification:
G01N 33/53
US Classification:
435 71
Abstract:
The present invention provides methods and materials, including kits, to evaluate Crohn's disease, including to diagnose, monitor, or determine the efficacy of treatment for Crohn's Disease. The methods involve determining the presence, absence, or level of zonulin in a subject sample. In certain embodiments, the need for more laborious and/or invasive tests to monitor disease state is minimized or obviated.

Blake Paterson Photo 6

Method For Treating Celiac Disease

US Patent:
8168594, May 1, 2012
Filed:
Nov 11, 2009
Appl. No.:
12/616638
Inventors:
Blake Paterson - Baltimore MD, US
Mark J. Ginski - Perry Hall MD, US
Assignee:
Alba Therapeutics Corporation - Baltimore MD
International Classification:
A61K 38/08
US Classification:
514 217
Abstract:
Enteric compositions comprising one or more tight junction agonists and/or one or more tight junction antagonists are provided. Compositions of the invention may comprise a delayed-release coating disposed over a tight junction agonist and/or tight junction antagonist layer which may be disposed over an inert core. Delayed-release coatings may be substantially stable in gastric fluid and substantially unstable in intestinal fluid, thus providing for substantial release of the tight junction agonist and/or antagonist from the composition in the duodenum or jejunum of the small intestine.

Blake Paterson Photo 7

Methods And Compositions For The Diagnosis Of Crohn's Disease

US Patent:
2013029, Nov 7, 2013
Filed:
May 1, 2012
Appl. No.:
13/460917
Inventors:
Julio Bai - Buenos Aires, AR
Alessio Fasano - West Friendship MD, US
Blake Paterson - Baltimore MD, US
Alicia Sambueli - Buenos Aires, AR
Assignee:
Alba Therapeutics Corporation - Baltimore MD
University of Maryland, Baltimore - Baltimore MD
International Classification:
G01N 33/68
US Classification:
435 794
Abstract:
The present invention provides methods and materials, including kits, to evaluate Crohn's disease, including to diagnose, monitor, or determine the efficacy of treatment for Crohn's Disease. The methods involve determining the presence, absence, or level of zonulin in a subject sample. In certain embodiments, the need for more laborious and/or invasive tests to monitor disease state is minimized or obviated.

Blake Paterson Photo 8

Method Of Diagnosing And Treating Asthma

US Patent:
2010014, Jun 10, 2010
Filed:
Nov 5, 2007
Appl. No.:
12/513336
Inventors:
Blake Paterson - Baltimore MD, US
International Classification:
A61K 38/08, G01N 33/53, A61P 11/08, A61P 11/06, G01N 33/567
US Classification:
514 16, 436 86, 435 721
Abstract:
The present invention provides materials and methods to diagnose asthma. In some embodiments, the present invention provides a method of diagnosing asthma by measuring the zonulin level of a subject. The present invention also provides methods and compositions for treating asthma that comprise one or more zonulin antagonist.

Blake Paterson Photo 9

Use Of Tight Junction Antagonists To Treat Inflammatory Bowel Disease

US Patent:
2009006, Mar 12, 2009
Filed:
Oct 9, 2007
Appl. No.:
11/869230
Inventors:
Blake Paterson - Baltimore MD, US
Amir Tamiz - Silver Spring MD, US
Niranjan Pandey - White Marsh MD, US
International Classification:
A61K 38/00, A61P 1/00
US Classification:
514 16, 514 2
Abstract:
The present invention provides materials and methods for the treatment of inflammatory bowel disease (e.g., Crohn's disease and ulcerative colitis). Materials of the invention may include compositions comprising one or more tight junction antagonists and optionally one or more therapeutic agents. Methods of the invention may comprise treating a subject in need thereof with a composition comprising one or more tight junction antagonists and, optionally one or more therapeutic agents.

Blake Paterson Photo 10

Transcutaneous Delivery Of Therapeutic Agents

US Patent:
2011014, Jun 16, 2011
Filed:
May 7, 2008
Appl. No.:
12/599430
Inventors:
Dorothea Sesardic - London, GB
Blake Paterson - Baltimore MD, US
Assignee:
Alba Therapeutics Corporation - Baltimore MD
International Classification:
A61K 39/145, A61K 38/08, A61K 38/28, A61K 39/00, A61K 39/05, A61K 39/10, A61K 39/165, A61K 39/20, A61K 39/08, A61K 39/07, A61K 39/102, A61K 39/275, A61P 37/04, A61P 3/10, A61P 31/12, A61P 31/14, A61P 31/16, A61P 31/20, A61P 31/04
US Classification:
4242091, 514 218, 514 217, 514 216, 514 59, 4241841, 4242451, 4242541, 4242121, 4242191, 4242471, 4242461, 4242561, 4242321
Abstract:
The present invention provides materials and methods to facilitate the transcutaneous delivery of therapeutic agents. In some embodiments, agonists of tight junctions are used in compositions to facilitate the uptake of therapeutic agents from the skin. In a particular embodiment, the present invention provides immunogenic compositions comprising a tight junction agonist and an antigen. In a particular embodiment, the present invention provides vaccine compositions comprising a tight junction agonist and an antigen.

Osteopathic Medicine licenses in Maryland










Other Doctors licenses in Maryland